Jasmin Siegle, Life Sciene Strategy Consultant

Highly accomplished Global Pricing & Market Access expert with significant experience in global product / TA strategy, launch pricing strategy, P&R plans, value proposition development and opportunity assessments.

Deep knowledge of US and EU payer market systems, particularly US MCOs, and interacting directly with payers and other key stakeholders in these markets.

Extensive experience in the oncology, CNS, immunology dermatology and CV spaces, including orphan indications.

Well-versed in championing cross-functional teams, mentoring talent, devising global strategic plans and local implementation strategies to drive results.

My focus is on serving life science & pharmaceutical clients by conducting consulting projects or working as an external consultant within client teams. My work consistently optimizes brand value, directs business development decisions and drives commercial planning as well as clinical development decisions.

Aquilae GmbH
Consultant
PHARMAZEUTISCHE INDUSTRIE
Mai 2019 - Heute (6 Jahre und 1 Monat)
Stuttgart, Deutschland
My focus is on serving life science & pharmaceutical clients by conducting consulting projects or working as an external consultant within client teams. Specifically, my capabilities include:
• Driving projects focused on global commercial as well as pricing, market access and reimbursement strategy for pharmaceutical and biotechnology companies of all sizes and across lifecycle stages
• Managing projects / project teams, conducting advanced analysis and developing insights to inform overall product and portfolio strategies as well as M&A and in-licensing / out-licensing decisions
• Applying deep knowledge of pricing, market access and reimbursement processes in the US and the EU to drive strategic recommendations
• My work consistently optimizes brand value, directs business development decisions and drives commercial planning as well as clinical development decisions

• List of example projects available on request
Windrose Consulting Group
Consultant
PHARMAZEUTISCHE INDUSTRIE
Februar 2016 - Mai 2019 (3 Jahre und 4 Monate)
Philadelphia, Vereinigte Staaten
• Managed over 30 EU-based and global projects focused on pricing & market access strategy for tier one pharmaceutical manufacturers
• Developed expert knowledge of US and EU markets and experienced working with payers across HTA markets, including DE, FR, UK and CA
• Directed internal teams to adhere to project milestones, collaborated with cross-functional client stakeholders, and delivered client-facing presentations

• List of example projects available on request
Scientific & Market Life Science Advising
Consultant
BIOTECHNOLOGIE
September 2014 - Januar 2016 (1 Jahr und 5 Monate)
St. Louis, Vereinigte Staaten
• Managed over 15 consulting projects focused on commercial strategy and pricing & market access for small to mid-sized biotechnology and digital health companies
• Delegated project deliverables to analysts and integrated team deliverables to synthesize cohesive reports
• Gained deep understanding of US and EU payer systems
• Developed analysts and served as point of contact for clients

(1 Meinung)

Qualität
Zuverlässigkeit
Kommunikation

Bewertungen von Jasmin ansehen

Katharina-NewtonX

24.10.2023

Jasmin war ein Glücksgriff für unser Projekt. Sie ist sehr erfahren in ihrem Metier, extrem professionell, und sehr verlässlich. Sie erledigt Aufgaben fristgerecht, in höchster Qualität und bringt stets neue Blickwinkel und Ideen ein. Sie ist mehr als nur eine Beraterin - sie ist eine echte Sparring Partnerin, die ich uneingeschränkt empfehlen kann.

Die Empfehlungen lesen, die Jasmin erhalten hat

Ausbildung und Abschlüsse von Jasmin ansehen

PhD
New York University
2015
Activities and societies: NYU Consulting Club, Columbia Graduate Consulting Club (CGCC)Activities and societies: NYU Consulting Club, Columbia Graduate Consulting Club (CGCC) Jasmin's research elucidated the similarities and differences in self-renewal and differentiation mechanisms between normal, epithelial stem cells and tumor-propagating cells in squamous cell carcinoma. Her work identified and characterized the role of a cancer-specific transcription factor in tumor-propagating cells in squamous cell carcinoma.
Master
New York University
2012
Bachelor
Drew University
2010
Grade: magna cum laudeGrade: magna cum laude Activities and societies: Tri-Beta (Honor Society in Biology) and Omicron Delta Epsilon (International Honor Society in Economics)Activities and societies: Tri-Beta (Honor Society in Biology) and Omicron Delta Epsilon (International Honor Society in Economics) Specialized Honors in Molecular Biology & Biochemistry studying genomic stability and DNA repair pathways in S. cerevisiae.